Armistice Capital »

Revelation Biosciences shares owned by Armistice Capital

Quarter-by-quarter ownership of Revelation Biosciences (REVB) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Revelation Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Revelation Biosciences held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revelation Biosciences by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $114k 80k 1.42

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Revelation Biosciences

Sabby Management
Armistice Capital
DRW Holdings
Jane Street
Tower Research Capital
SBI Securities
UBS Group
Danske Bank A/s

View all funds holding Revelation Biosciences